APO Research
Talk to an analyst

APO RESEARCH · REPORT

Red Blood Cell Products

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Red Blood Cell Products Market Analysis and Forecast 2026-2032

23 December 2025204 pages

Choose your research edition.

Industry ResearchRed Blood Cell Products Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Red Blood Cell Products Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Red Blood Cell Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Red Blood Cell Products Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Red Blood Cell Products Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Red Blood Cell Products market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Red Blood Cell Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Red Blood Cell Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Red Blood Cell Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Red Blood Cell Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Red Blood Cell Products include China National Biotec Group, Weiguang Biological, Tiantan Biological, Shanghai RAAS Blood Products, Pilin Biological, Hualan Biological, Boyaa Bio-pharmaceutical, Bohui Innovation and Takeda Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Red Blood Cell Products, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Red Blood Cell Products, also provides the sales of main regions and countries. Of the upcoming market potential for Red Blood Cell Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Red Blood Cell Products sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Red Blood Cell Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Red Blood Cell Products sales, projected growth trends, production technology, application and end-user industry.

Red Blood Cell Products Segment by Company

China National Biotec Group

Weiguang Biological

Tiantan Biological

Shanghai RAAS Blood Products

Pilin Biological

Hualan Biological

Boyaa Bio-pharmaceutical

Bohui Innovation

Takeda Pharmaceutical

Sangamo Therapeutics

Octapharma

LFB Group

Kedrion

Kamada

Hemophilia Federation Europe

Grifols

Emergent BioSolutions

CSL Behring

Biotest

American Red Cross

Red Blood Cell Products Segment by Type

Washed Red Blood Cells

Concentrated Red Blood Cells

Frozen Red Blood Cells

Red Blood Cell Suspension

Irradiated Red Blood Cells

Others

Red Blood Cell Products Segment by Application

Blood Disease Supportive Treatment

Special Disease Management

Anemia Treatment

Acute Hemorrhage

Red Blood Cell Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Red Blood Cell Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Red Blood Cell Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Red Blood Cell Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Red Blood Cell Products in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Red Blood Cell Products manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Red Blood Cell Products sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Red Blood Cell Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Washed Red Blood Cells Major Manufacturers Table 3. Concentrated Red Blood Cells Major Manufacturers Table 4. Frozen Red Blood Cells Major Manufacturers Table 5. Red Blood Cell Suspension Major Manufacturers Table 6. Irradiated Red Blood Cells Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Red Blood Cell Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Blood Disease Supportive Treatment Major Manufacturers Table 10. Special Disease Management Major Manufacturers Table 11. Anemia Treatment Major Manufacturers Table 12. Acute Hemorrhage Major Manufacturers Table 13. Red Blood Cell Products Industry Trends Table 14. Red Blood Cell Products Industry Drivers Table 15. Red Blood Cell Products Industry Opportunities and Challenges Table 16. Red Blood Cell Products Industry Restraints Table 17. Global Red Blood Cell Products Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Red Blood Cell Products Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Red Blood Cell Products Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Red Blood Cell Products Revenue Market Share by Region (2021-2026) Table 21. Global Red Blood Cell Products Revenue Market Share by Region (2027-2032) Table 22. Global Red Blood Cell Products Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (units) Table 23. Global Red Blood Cell Products Sales by Region (2021-2026) & (units) Table 24. Global Red Blood Cell Products Sales by Region (2027-2032) & (units) Table 25. Global Red Blood Cell Products Sales Market Share by Region (2021-2026) Table 26. Global Red Blood Cell Products Sales Market Share by Region (2027-2032) Table 27. Global Red Blood Cell Products Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Red Blood Cell Products Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Red Blood Cell Products Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Red Blood Cell Products Sales Market Share by Manufacturers (2021-2026) Table 31. Global Red Blood Cell Products Sales Price (USD/unit) of Manufacturers (2021-2026) Table 32. Global Red Blood Cell Products Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Red Blood Cell Products Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Red Blood Cell Products Manufacturers, Product Type & Application Table 35. Global Red Blood Cell Products Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Red Blood Cell Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Red Blood Cell Products Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Red Blood Cell Products Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Red Blood Cell Products Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Red Blood Cell Products Revenue Market Share by Type (2021-2026) Table 42. Global Red Blood Cell Products Revenue Market Share by Type (2027-2032) Table 43. Global Red Blood Cell Products Sales by Type 2021 VS 2025 VS 2032 (units) Table 44. Global Red Blood Cell Products Sales by Type (2021-2026) & (units) Table 45. Global Red Blood Cell Products Sales by Type (2027-2032) & (units) Table 46. Global Red Blood Cell Products Sales Market Share by Type (2021-2026) Table 47. Global Red Blood Cell Products Sales Market Share by Type (2027-2032) Table 48. Global Red Blood Cell Products Price by Type (2021-2026) & (USD/unit) Table 49. Global Red Blood Cell Products Price by Type (2027-2032) & (USD/unit) Table 50. Global Red Blood Cell Products Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Red Blood Cell Products Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Red Blood Cell Products Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Red Blood Cell Products Revenue Market Share by Application (2021-2026) Table 54. Global Red Blood Cell Products Revenue Market Share by Application (2027-2032) Table 55. Global Red Blood Cell Products Sales by Application 2021 VS 2025 VS 2032 (units) Table 56. Global Red Blood Cell Products Sales by Application (2021-2026) & (units) Table 57. Global Red Blood Cell Products Sales by Application (2027-2032) & (units) Table 58. Global Red Blood Cell Products Sales Market Share by Application (2021-2026) Table 59. Global Red Blood Cell Products Sales Market Share by Application (2027-2032) Table 60. Global Red Blood Cell Products Price by Application (2021-2026) & (USD/unit) Table 61. Global Red Blood Cell Products Price by Application (2027-2032) & (USD/unit) Table 62. China National Biotec Group Company Information Table 63. China National Biotec Group Business Overview Table 64. China National Biotec Group Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 65. China National Biotec Group Red Blood Cell Products Product Portfolio Table 66. China National Biotec Group Recent Development Table 67. Weiguang Biological Company Information Table 68. Weiguang Biological Business Overview Table 69. Weiguang Biological Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. Weiguang Biological Red Blood Cell Products Product Portfolio Table 71. Weiguang Biological Recent Development Table 72. Tiantan Biological Company Information Table 73. Tiantan Biological Business Overview Table 74. Tiantan Biological Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Tiantan Biological Red Blood Cell Products Product Portfolio Table 76. Tiantan Biological Recent Development Table 77. Shanghai RAAS Blood Products Company Information Table 78. Shanghai RAAS Blood Products Business Overview Table 79. Shanghai RAAS Blood Products Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Shanghai RAAS Blood Products Red Blood Cell Products Product Portfolio Table 81. Shanghai RAAS Blood Products Recent Development Table 82. Pilin Biological Company Information Table 83. Pilin Biological Business Overview Table 84. Pilin Biological Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Pilin Biological Red Blood Cell Products Product Portfolio Table 86. Pilin Biological Recent Development Table 87. Hualan Biological Company Information Table 88. Hualan Biological Business Overview Table 89. Hualan Biological Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Hualan Biological Red Blood Cell Products Product Portfolio Table 91. Hualan Biological Recent Development Table 92. Boyaa Bio-pharmaceutical Company Information Table 93. Boyaa Bio-pharmaceutical Business Overview Table 94. Boyaa Bio-pharmaceutical Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Boyaa Bio-pharmaceutical Red Blood Cell Products Product Portfolio Table 96. Boyaa Bio-pharmaceutical Recent Development Table 97. Bohui Innovation Company Information Table 98. Bohui Innovation Business Overview Table 99. Bohui Innovation Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Bohui Innovation Red Blood Cell Products Product Portfolio Table 101. Bohui Innovation Recent Development Table 102. Takeda Pharmaceutical Company Information Table 103. Takeda Pharmaceutical Business Overview Table 104. Takeda Pharmaceutical Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Takeda Pharmaceutical Red Blood Cell Products Product Portfolio Table 106. Takeda Pharmaceutical Recent Development Table 107. Sangamo Therapeutics Company Information Table 108. Sangamo Therapeutics Business Overview Table 109. Sangamo Therapeutics Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Sangamo Therapeutics Red Blood Cell Products Product Portfolio Table 111. Sangamo Therapeutics Recent Development Table 112. Octapharma Company Information Table 113. Octapharma Business Overview Table 114. Octapharma Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Octapharma Red Blood Cell Products Product Portfolio Table 116. Octapharma Recent Development Table 117. LFB Group Company Information Table 118. LFB Group Business Overview Table 119. LFB Group Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. LFB Group Red Blood Cell Products Product Portfolio Table 121. LFB Group Recent Development Table 122. Kedrion Company Information Table 123. Kedrion Business Overview Table 124. Kedrion Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Kedrion Red Blood Cell Products Product Portfolio Table 126. Kedrion Recent Development Table 127. Kamada Company Information Table 128. Kamada Business Overview Table 129. Kamada Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Kamada Red Blood Cell Products Product Portfolio Table 131. Kamada Recent Development Table 132. Hemophilia Federation Europe Company Information Table 133. Hemophilia Federation Europe Business Overview Table 134. Hemophilia Federation Europe Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Hemophilia Federation Europe Red Blood Cell Products Product Portfolio Table 136. Hemophilia Federation Europe Recent Development Table 137. Grifols Company Information Table 138. Grifols Business Overview Table 139. Grifols Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Grifols Red Blood Cell Products Product Portfolio Table 141. Grifols Recent Development Table 142. Emergent BioSolutions Company Information Table 143. Emergent BioSolutions Business Overview Table 144. Emergent BioSolutions Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Emergent BioSolutions Red Blood Cell Products Product Portfolio Table 146. Emergent BioSolutions Recent Development Table 147. CSL Behring Company Information Table 148. CSL Behring Business Overview Table 149. CSL Behring Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. CSL Behring Red Blood Cell Products Product Portfolio Table 151. CSL Behring Recent Development Table 152. Biotest Company Information Table 153. Biotest Business Overview Table 154. Biotest Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Biotest Red Blood Cell Products Product Portfolio Table 156. Biotest Recent Development Table 157. American Red Cross Company Information Table 158. American Red Cross Business Overview Table 159. American Red Cross Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. American Red Cross Red Blood Cell Products Product Portfolio Table 161. American Red Cross Recent Development Table 162. North America Red Blood Cell Products Revenue by Type (2021-2026) & (US$ Million) Table 163. North America Red Blood Cell Products Revenue by Type (2027-2032) & (US$ Million) Table 164. North America Red Blood Cell Products Sales by Type (2021-2026) & (units) Table 165. North America Red Blood Cell Products Sales by Type (2027-2032) & (units) Table 166. North America Red Blood Cell Products Sales Price by Type (2021-2026) & (USD/unit) Table 167. North America Red Blood Cell Products Sales Price by Type (2027-2032) & (USD/unit) Table 168. North America Red Blood Cell Products Revenue by Application (2021-2026) & (US$ Million) Table 169. North America Red Blood Cell Products Revenue by Application (2027-2032) & (US$ Million) Table 170. North America Red Blood Cell Products Sales by Application (2021-2026) & (units) Table 171. North America Red Blood Cell Products Sales by Application (2027-2032) & (units) Table 172. North America Red Blood Cell Products Sales Price by Application (2021-2026) & (USD/unit) Table 173. North America Red Blood Cell Products Sales Price by Application (2027-2032) & (USD/unit) Table 174. North America Red Blood Cell Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. North America Red Blood Cell Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. North America Red Blood Cell Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. North America Red Blood Cell Products Sales by Country (2021 VS 2025 VS 2032) & (units) Table 178. North America Red Blood Cell Products Sales by Country (2021-2026) & (units) Table 179. North America Red Blood Cell Products Sales by Country (2027-2032) & (units) Table 180. North America Red Blood Cell Products Sales Price by Country (2021-2026) & (USD/unit) Table 181. North America Red Blood Cell Products Sales Price by Country (2027-2032) & (USD/unit) Table 182. United States Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 183. Canada Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 184. Mexico Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 185. Europe Red Blood Cell Products Revenue by Type (2021-2026) & (US$ Million) Table 186. Europe Red Blood Cell Products Revenue by Type (2027-2032) & (US$ Million) Table 187. Europe Red Blood Cell Products Sales by Type (2021-2026) & (units) Table 188. Europe Red Blood Cell Products Sales by Type (2027-2032) & (units) Table 189. Europe Red Blood Cell Products Sales Price by Type (2021-2026) & (USD/unit) Table 190. Europe Red Blood Cell Products Sales Price by Type (2027-2032) & (USD/unit) Table 191. Europe Red Blood Cell Products Revenue by Application (2021-2026) & (US$ Million) Table 192. Europe Red Blood Cell Products Revenue by Application (2027-2032) & (US$ Million) Table 193. Europe Red Blood Cell Products Sales by Application (2021-2026) & (units) Table 194. Europe Red Blood Cell Products Sales by Application (2027-2032) & (units) Table 195. Europe Red Blood Cell Products Sales Price by Application (2021-2026) & (USD/unit) Table 196. Europe Red Blood Cell Products Sales Price by Application (2027-2032) & (USD/unit) Table 197. Europe Red Blood Cell Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 198. Europe Red Blood Cell Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 199. Europe Red Blood Cell Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 200. Europe Red Blood Cell Products Sales by Country (2021 VS 2025 VS 2032) & (units) Table 201. Europe Red Blood Cell Products Sales by Country (2021-2026) & (units) Table 202. Europe Red Blood Cell Products Sales by Country (2027-2032) & (units) Table 203. Europe Red Blood Cell Products Sales Price by Country (2021-2026) & (USD/unit) Table 204. Europe Red Blood Cell Products Sales Price by Country (2027-2032) & (USD/unit) Table 205. Germany Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 206. France Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 207. U.K. Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 208. Italy Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 209. Russia Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 210. Spain Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 211. Netherlands Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 212. Switzerland Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 213. Sweden Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 214. Poland Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 215. China Red Blood Cell Products Revenue by Type (2021-2026) & (US$ Million) Table 216. China Red Blood Cell Products Revenue by Type (2027-2032) & (US$ Million) Table 217. China Red Blood Cell Products Sales by Type (2021-2026) & (units) Table 218. China Red Blood Cell Products Sales by Type (2027-2032) & (units) Table 219. China Red Blood Cell Products Sales Price by Type (2021-2026) & (USD/unit) Table 220. China Red Blood Cell Products Sales Price by Type (2027-2032) & (USD/unit) Table 221. China Red Blood Cell Products Revenue by Application (2021-2026) & (US$ Million) Table 222. China Red Blood Cell Products Revenue by Application (2027-2032) & (US$ Million) Table 223. China Red Blood Cell Products Sales by Application (2021-2026) & (units) Table 224. China Red Blood Cell Products Sales by Application (2027-2032) & (units) Table 225. China Red Blood Cell Products Sales Price by Application (2021-2026) & (USD/unit) Table 226. China Red Blood Cell Products Sales Price by Application (2027-2032) & (USD/unit) Table 227. Asia Red Blood Cell Products Revenue by Type (2021-2026) & (US$ Million) Table 228. Asia Red Blood Cell Products Revenue by Type (2027-2032) & (US$ Million) Table 229. Asia Red Blood Cell Products Sales by Type (2021-2026) & (units) Table 230. Asia Red Blood Cell Products Sales by Type (2027-2032) & (units) Table 231. Asia Red Blood Cell Products Sales Price by Type (2021-2026) & (USD/unit) Table 232. Asia Red Blood Cell Products Sales Price by Type (2027-2032) & (USD/unit) Table 233. Asia Red Blood Cell Products Revenue by Application (2021-2026) & (US$ Million) Table 234. Asia Red Blood Cell Products Revenue by Application (2027-2032) & (US$ Million) Table 235. Asia Red Blood Cell Products Sales by Application (2021-2026) & (units) Table 236. Asia Red Blood Cell Products Sales by Application (2027-2032) & (units) Table 237. Asia Red Blood Cell Products Sales Price by Application (2021-2026) & (USD/unit) Table 238. Asia Red Blood Cell Products Sales Price by Application (2027-2032) & (USD/unit) Table 239. Asia Red Blood Cell Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 240. Asia Red Blood Cell Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 241. Asia Red Blood Cell Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 242. Asia Red Blood Cell Products Sales by Country (2021 VS 2025 VS 2032) & (units) Table 243. Asia Red Blood Cell Products Sales by Country (2021-2026) & (units) Table 244. Asia Red Blood Cell Products Sales by Country (2027-2032) & (units) Table 245. Asia Red Blood Cell Products Sales Price by Country (2021-2026) & (USD/unit) Table 246. Asia Red Blood Cell Products Sales Price by Country (2027-2032) & (USD/unit) Table 247. Japan Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 248. South Korea Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 249. India Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 250. Australia Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 251. Taiwan Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 252. Southeast Asia Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 253. SAMEA Red Blood Cell Products Revenue by Type (2021-2026) & (US$ Million) Table 254. SAMEA Red Blood Cell Products Revenue by Type (2027-2032) & (US$ Million) Table 255. SAMEA Red Blood Cell Products Sales by Type (2021-2026) & (units) Table 256. SAMEA Red Blood Cell Products Sales by Type (2027-2032) & (units) Table 257. SAMEA Red Blood Cell Products Sales Price by Type (2021-2026) & (USD/unit) Table 258. SAMEA Red Blood Cell Products Sales Price by Type (2027-2032) & (USD/unit) Table 259. SAMEA Red Blood Cell Products Revenue by Application (2021-2026) & (US$ Million) Table 260. SAMEA Red Blood Cell Products Revenue by Application (2027-2032) & (US$ Million) Table 261. SAMEA Red Blood Cell Products Sales by Application (2021-2026) & (units) Table 262. SAMEA Red Blood Cell Products Sales by Application (2027-2032) & (units) Table 263. SAMEA Red Blood Cell Products Sales Price by Application (2021-2026) & (USD/unit) Table 264. SAMEA Red Blood Cell Products Sales Price by Application (2027-2032) & (USD/unit) Table 265. SAMEA Red Blood Cell Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 266. SAMEA Red Blood Cell Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 267. SAMEA Red Blood Cell Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 268. SAMEA Red Blood Cell Products Sales by Country (2021 VS 2025 VS 2032) & (units) Table 269. SAMEA Red Blood Cell Products Sales by Country (2021-2026) & (units) Table 270. SAMEA Red Blood Cell Products Sales by Country (2027-2032) & (units) Table 271. SAMEA Red Blood Cell Products Sales Price by Country (2021-2026) & (USD/unit) Table 272. SAMEA Red Blood Cell Products Sales Price by Country (2027-2032) & (USD/unit) Table 273. Brazil Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 274. Argentina Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 275. Chile Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 276. Colombia Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 277. Peru Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 278. Saudi Arabia Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 279. Israel Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 280. UAE Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 281. Turkey Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 282. Iran Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 283. Egypt Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Table 284. Key Raw Materials Table 285. Raw Materials Key Suppliers Table 286. Red Blood Cell Products Distributors List Table 287. Red Blood Cell Products Customers List Table 288. Research Programs/Design for This Report Table 289. Authors List of This Report Table 290. Secondary Sources Table 291. Primary Sources List of Figures Figure 1. Red Blood Cell Products Image Figure 2. Global Red Blood Cell Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Red Blood Cell Products Market Size Share 2021 VS 2025 VS 2032 Figure 4. Washed Red Blood Cells Image Figure 5. Concentrated Red Blood Cells Image Figure 6. Frozen Red Blood Cells Image Figure 7. Red Blood Cell Suspension Image Figure 8. Irradiated Red Blood Cells Image Figure 9. Others Image Figure 10. Global Red Blood Cell Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Red Blood Cell Products Market Size Share 2021 VS 2025 VS 2032 Figure 12. Blood Disease Supportive Treatment Image Figure 13. Special Disease Management Image Figure 14. Anemia Treatment Image Figure 15. Acute Hemorrhage Image Figure 16. Global Red Blood Cell Products Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Figure 18. Global Red Blood Cell Products Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Red Blood Cell Products Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Red Blood Cell Products Revenue Market Share by Region (2021-2032) Figure 21. Global Red Blood Cell Products Sales (2021-2032) & (units) Figure 22. Global Red Blood Cell Products Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 23. Global Red Blood Cell Products Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Red Blood Cell Products Sales YoY (2021-2032) & (units) Figure 25. Europe Red Blood Cell Products Sales YoY (2021-2032) & (units) Figure 26. China Red Blood Cell Products Sales YoY (2021-2032) & (units) Figure 27. Asia (Excluding China) Red Blood Cell Products Sales YoY (2021-2032) & (units) Figure 28. South America, Middle East and Africa Red Blood Cell Products Sales YoY (2021-2032) & (units) Figure 29. Global Red Blood Cell Products Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Red Blood Cell Products Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Red Blood Cell Products Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Red Blood Cell Products Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Red Blood Cell Products Revenue Market Share by Type (2021-2032) Figure 35. Global Red Blood Cell Products Sales by Type (2021 VS 2025 VS 2032) & (units) Figure 36. Global Red Blood Cell Products Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Red Blood Cell Products Sales Market Share by Type (2021-2032) Figure 38. Global Red Blood Cell Products Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Red Blood Cell Products Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Red Blood Cell Products Revenue Market Share by Application (2021-2032) Figure 41. Global Red Blood Cell Products Sales by Application (2021 VS 2025 VS 2032) & (units) Figure 42. Global Red Blood Cell Products Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Red Blood Cell Products Sales Market Share by Application (2021-2032) Figure 44. North America Red Blood Cell Products Revenue Share by Type (2021-2032) Figure 45. North America Red Blood Cell Products Sales Share by Type (2021-2032) Figure 46. North America Red Blood Cell Products Revenue Share by Application (2021-2032) Figure 47. North America Red Blood Cell Products Sales Share by Application (2021-2032) Figure 48. North America Red Blood Cell Products Revenue Share by Country (2021-2032) Figure 49. North America Red Blood Cell Products Sales Share by Country (2021-2032) Figure 50. Europe Red Blood Cell Products Revenue Share by Type (2021-2032) Figure 51. Europe Red Blood Cell Products Sales Share by Type (2021-2032) Figure 52. Europe Red Blood Cell Products Revenue Share by Application (2021-2032) Figure 53. Europe Red Blood Cell Products Sales Share by Application (2021-2032) Figure 54. Europe Red Blood Cell Products Revenue Share by Country (2021-2032) Figure 55. Europe Red Blood Cell Products Sales Share by Country (2021-2032) Figure 56. China Red Blood Cell Products Revenue Share by Type (2021-2032) Figure 57. China Red Blood Cell Products Sales Share by Type (2021-2032) Figure 58. China Red Blood Cell Products Revenue Share by Application (2021-2032) Figure 59. China Red Blood Cell Products Sales Share by Application (2021-2032) Figure 60. Asia Red Blood Cell Products Revenue Share by Type (2021-2032) Figure 61. Asia Red Blood Cell Products Sales Share by Type (2021-2032) Figure 62. Asia Red Blood Cell Products Revenue Share by Application (2021-2032) Figure 63. Asia Red Blood Cell Products Sales Share by Application (2021-2032) Figure 64. Asia Red Blood Cell Products Revenue Share by Country (2021-2032) Figure 65. Asia Red Blood Cell Products Sales Share by Country (2021-2032) Figure 66. SAMEA Red Blood Cell Products Revenue Share by Type (2021-2032) Figure 67. SAMEA Red Blood Cell Products Sales Share by Type (2021-2032) Figure 68. SAMEA Red Blood Cell Products Revenue Share by Application (2021-2032) Figure 69. SAMEA Red Blood Cell Products Sales Share by Application (2021-2032) Figure 70. SAMEA Red Blood Cell Products Revenue Share by Country (2021-2032) Figure 71. SAMEA Red Blood Cell Products Sales Share by Country (2021-2032) Figure 72. Red Blood Cell Products Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Red Blood Cell Products Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Washed Red Blood Cells
  • Concentrated Red Blood Cells
  • Frozen Red Blood Cells
  • Red Blood Cell Suspension
  • Irradiated Red Blood Cells
  • Others
Applications
  • Blood Disease Supportive Treatment
  • Special Disease Management
  • Anemia Treatment
  • Acute Hemorrhage
Companies covered
  • China National Biotec Group
  • Weiguang Biological
  • Tiantan Biological
  • Shanghai RAAS Blood Products
  • Pilin Biological
  • Hualan Biological
  • Boyaa Bio-pharmaceutical
  • Bohui Innovation
  • Takeda Pharmaceutical
  • Sangamo Therapeutics
  • Octapharma
  • LFB Group
  • Kedrion
  • Kamada
  • Hemophilia Federation Europe
  • Grifols
  • Emergent BioSolutions
  • CSL Behring
  • Biotest
  • American Red Cross

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Red Blood Cell Products Market by Type
  3. 1.2.1 Global Red Blood Cell Products Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Washed Red Blood Cells
  5. 1.2.3 Concentrated Red Blood Cells
  6. 1.2.4 Frozen Red Blood Cells
  7. 1.2.5 Red Blood Cell Suspension
  8. 1.2.6 Irradiated Red Blood Cells
  9. 1.2.7 Others
  10. 1.3 Red Blood Cell Products Market by Application
  11. 1.3.1 Global Red Blood Cell Products Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Blood Disease Supportive Treatment
  13. 1.3.3 Special Disease Management
  14. 1.3.4 Anemia Treatment
  15. 1.3.5 Acute Hemorrhage
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Red Blood Cell Products Market Dynamics
  1. 2.1 Red Blood Cell Products Industry Trends
  2. 2.2 Red Blood Cell Products Industry Drivers
  3. 2.3 Red Blood Cell Products Industry Opportunities and Challenges
  4. 2.4 Red Blood Cell Products Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Red Blood Cell Products Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Red Blood Cell Products Revenue by Region
  3. 3.2.1 Global Red Blood Cell Products Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Red Blood Cell Products Revenue by Region (2021-2026)
  5. 3.2.3 Global Red Blood Cell Products Revenue by Region (2027-2032)
  6. 3.2.4 Global Red Blood Cell Products Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Red Blood Cell Products Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Red Blood Cell Products Sales by Region
  9. 3.4.1 Global Red Blood Cell Products Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Red Blood Cell Products Sales by Region (2021-2026)
  11. 3.4.3 Global Red Blood Cell Products Sales by Region (2027-2032)
  12. 3.4.4 Global Red Blood Cell Products Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Red Blood Cell Products Revenue by Manufacturers
  2. 4.1.1 Global Red Blood Cell Products Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Red Blood Cell Products Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Red Blood Cell Products Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Red Blood Cell Products Sales by Manufacturers
  6. 4.2.1 Global Red Blood Cell Products Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Red Blood Cell Products Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Red Blood Cell Products Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Red Blood Cell Products Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Red Blood Cell Products Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Red Blood Cell Products Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Red Blood Cell Products Manufacturers, Product Type & Application
  13. 4.7 Global Red Blood Cell Products Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Red Blood Cell Products Market CR5 and HHI
  16. 4.8.2 2025 Red Blood Cell Products Tier 1, Tier 2, and Tier 3
5 Red Blood Cell Products Market by Type
  1. 5.1 Global Red Blood Cell Products Revenue by Type
  2. 5.1.1 Global Red Blood Cell Products Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Red Blood Cell Products Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Red Blood Cell Products Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Red Blood Cell Products Sales by Type
  6. 5.2.1 Global Red Blood Cell Products Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Red Blood Cell Products Sales by Type (2021-2032) & (units)
  8. 5.2.3 Global Red Blood Cell Products Sales Market Share by Type (2021-2032)
  9. 5.3 Global Red Blood Cell Products Price by Type
6 Red Blood Cell Products Market by Application
  1. 6.1 Global Red Blood Cell Products Revenue by Application
  2. 6.1.1 Global Red Blood Cell Products Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Red Blood Cell Products Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Red Blood Cell Products Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Red Blood Cell Products Sales by Application
  6. 6.2.1 Global Red Blood Cell Products Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Red Blood Cell Products Sales by Application (2021-2032) & (units)
  8. 6.2.3 Global Red Blood Cell Products Sales Market Share by Application (2021-2032)
  9. 6.3 Global Red Blood Cell Products Price by Application
7 Company Profiles
  1. 7.1 China National Biotec Group
  2. 7.1.1 China National Biotec Group Company Information
  3. 7.1.2 China National Biotec Group Business Overview
  4. 7.1.3 China National Biotec Group Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 China National Biotec Group Red Blood Cell Products Product Portfolio
  6. 7.1.5 China National Biotec Group Recent Developments
  7. 7.2 Weiguang Biological
  8. 7.2.1 Weiguang Biological Company Information
  9. 7.2.2 Weiguang Biological Business Overview
  10. 7.2.3 Weiguang Biological Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Weiguang Biological Red Blood Cell Products Product Portfolio
  12. 7.2.5 Weiguang Biological Recent Developments
  13. 7.3 Tiantan Biological
  14. 7.3.1 Tiantan Biological Company Information
  15. 7.3.2 Tiantan Biological Business Overview
  16. 7.3.3 Tiantan Biological Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Tiantan Biological Red Blood Cell Products Product Portfolio
  18. 7.3.5 Tiantan Biological Recent Developments
  19. 7.4 Shanghai RAAS Blood Products
  20. 7.4.1 Shanghai RAAS Blood Products Company Information
  21. 7.4.2 Shanghai RAAS Blood Products Business Overview
  22. 7.4.3 Shanghai RAAS Blood Products Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Shanghai RAAS Blood Products Red Blood Cell Products Product Portfolio
  24. 7.4.5 Shanghai RAAS Blood Products Recent Developments
  25. 7.5 Pilin Biological
  26. 7.5.1 Pilin Biological Company Information
  27. 7.5.2 Pilin Biological Business Overview
  28. 7.5.3 Pilin Biological Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pilin Biological Red Blood Cell Products Product Portfolio
  30. 7.5.5 Pilin Biological Recent Developments
  31. 7.6 Hualan Biological
  32. 7.6.1 Hualan Biological Company Information
  33. 7.6.2 Hualan Biological Business Overview
  34. 7.6.3 Hualan Biological Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hualan Biological Red Blood Cell Products Product Portfolio
  36. 7.6.5 Hualan Biological Recent Developments
  37. 7.7 Boyaa Bio-pharmaceutical
  38. 7.7.1 Boyaa Bio-pharmaceutical Company Information
  39. 7.7.2 Boyaa Bio-pharmaceutical Business Overview
  40. 7.7.3 Boyaa Bio-pharmaceutical Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Boyaa Bio-pharmaceutical Red Blood Cell Products Product Portfolio
  42. 7.7.5 Boyaa Bio-pharmaceutical Recent Developments
  43. 7.8 Bohui Innovation
  44. 7.8.1 Bohui Innovation Company Information
  45. 7.8.2 Bohui Innovation Business Overview
  46. 7.8.3 Bohui Innovation Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Bohui Innovation Red Blood Cell Products Product Portfolio
  48. 7.8.5 Bohui Innovation Recent Developments
  49. 7.9 Takeda Pharmaceutical
  50. 7.9.1 Takeda Pharmaceutical Company Information
  51. 7.9.2 Takeda Pharmaceutical Business Overview
  52. 7.9.3 Takeda Pharmaceutical Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Takeda Pharmaceutical Red Blood Cell Products Product Portfolio
  54. 7.9.5 Takeda Pharmaceutical Recent Developments
  55. 7.10 Sangamo Therapeutics
  56. 7.10.1 Sangamo Therapeutics Company Information
  57. 7.10.2 Sangamo Therapeutics Business Overview
  58. 7.10.3 Sangamo Therapeutics Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sangamo Therapeutics Red Blood Cell Products Product Portfolio
  60. 7.10.5 Sangamo Therapeutics Recent Developments
  61. 7.11 Octapharma
  62. 7.11.1 Octapharma Company Information
  63. 7.11.2 Octapharma Business Overview
  64. 7.11.3 Octapharma Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Octapharma Red Blood Cell Products Product Portfolio
  66. 7.11.5 Octapharma Recent Developments
  67. 7.12 LFB Group
  68. 7.12.1 LFB Group Company Information
  69. 7.12.2 LFB Group Business Overview
  70. 7.12.3 LFB Group Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 LFB Group Red Blood Cell Products Product Portfolio
  72. 7.12.5 LFB Group Recent Developments
  73. 7.13 Kedrion
  74. 7.13.1 Kedrion Company Information
  75. 7.13.2 Kedrion Business Overview
  76. 7.13.3 Kedrion Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Kedrion Red Blood Cell Products Product Portfolio
  78. 7.13.5 Kedrion Recent Developments
  79. 7.14 Kamada
  80. 7.14.1 Kamada Company Information
  81. 7.14.2 Kamada Business Overview
  82. 7.14.3 Kamada Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Kamada Red Blood Cell Products Product Portfolio
  84. 7.14.5 Kamada Recent Developments
  85. 7.15 Hemophilia Federation Europe
  86. 7.15.1 Hemophilia Federation Europe Company Information
  87. 7.15.2 Hemophilia Federation Europe Business Overview
  88. 7.15.3 Hemophilia Federation Europe Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Hemophilia Federation Europe Red Blood Cell Products Product Portfolio
  90. 7.15.5 Hemophilia Federation Europe Recent Developments
  91. 7.16 Grifols
  92. 7.16.1 Grifols Company Information
  93. 7.16.2 Grifols Business Overview
  94. 7.16.3 Grifols Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Grifols Red Blood Cell Products Product Portfolio
  96. 7.16.5 Grifols Recent Developments
  97. 7.17 Emergent BioSolutions
  98. 7.17.1 Emergent BioSolutions Company Information
  99. 7.17.2 Emergent BioSolutions Business Overview
  100. 7.17.3 Emergent BioSolutions Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Emergent BioSolutions Red Blood Cell Products Product Portfolio
  102. 7.17.5 Emergent BioSolutions Recent Developments
  103. 7.18 CSL Behring
  104. 7.18.1 CSL Behring Company Information
  105. 7.18.2 CSL Behring Business Overview
  106. 7.18.3 CSL Behring Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 CSL Behring Red Blood Cell Products Product Portfolio
  108. 7.18.5 CSL Behring Recent Developments
  109. 7.19 Biotest
  110. 7.19.1 Biotest Company Information
  111. 7.19.2 Biotest Business Overview
  112. 7.19.3 Biotest Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Biotest Red Blood Cell Products Product Portfolio
  114. 7.19.5 Biotest Recent Developments
  115. 7.20 American Red Cross
  116. 7.20.1 American Red Cross Company Information
  117. 7.20.2 American Red Cross Business Overview
  118. 7.20.3 American Red Cross Red Blood Cell Products Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 American Red Cross Red Blood Cell Products Product Portfolio
  120. 7.20.5 American Red Cross Recent Developments
8 North America
  1. 8.1 North America Red Blood Cell Products Market Size by Type
  2. 8.1.1 North America Red Blood Cell Products Revenue by Type (2021-2032)
  3. 8.1.2 North America Red Blood Cell Products Sales by Type (2021-2032)
  4. 8.1.3 North America Red Blood Cell Products Price by Type (2021-2032)
  5. 8.2 North America Red Blood Cell Products Market Size by Application
  6. 8.2.1 North America Red Blood Cell Products Revenue by Application (2021-2032)
  7. 8.2.2 North America Red Blood Cell Products Sales by Application (2021-2032)
  8. 8.2.3 North America Red Blood Cell Products Price by Application (2021-2032)
  9. 8.3 North America Red Blood Cell Products Market Size by Country
  10. 8.3.1 North America Red Blood Cell Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Red Blood Cell Products Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Red Blood Cell Products Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Red Blood Cell Products Market Size by Type
  2. 9.1.1 Europe Red Blood Cell Products Revenue by Type (2021-2032)
  3. 9.1.2 Europe Red Blood Cell Products Sales by Type (2021-2032)
  4. 9.1.3 Europe Red Blood Cell Products Price by Type (2021-2032)
  5. 9.2 Europe Red Blood Cell Products Market Size by Application
  6. 9.2.1 Europe Red Blood Cell Products Revenue by Application (2021-2032)
  7. 9.2.2 Europe Red Blood Cell Products Sales by Application (2021-2032)
  8. 9.2.3 Europe Red Blood Cell Products Price by Application (2021-2032)
  9. 9.3 Europe Red Blood Cell Products Market Size by Country
  10. 9.3.1 Europe Red Blood Cell Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Red Blood Cell Products Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Red Blood Cell Products Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Red Blood Cell Products Market Size by Type
  2. 10.1.1 China Red Blood Cell Products Revenue by Type (2021-2032)
  3. 10.1.2 China Red Blood Cell Products Sales by Type (2021-2032)
  4. 10.1.3 China Red Blood Cell Products Price by Type (2021-2032)
  5. 10.2 China Red Blood Cell Products Market Size by Application
  6. 10.2.1 China Red Blood Cell Products Revenue by Application (2021-2032)
  7. 10.2.2 China Red Blood Cell Products Sales by Application (2021-2032)
  8. 10.2.3 China Red Blood Cell Products Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Red Blood Cell Products Market Size by Type
  2. 11.1.1 Asia Red Blood Cell Products Revenue by Type (2021-2032)
  3. 11.1.2 Asia Red Blood Cell Products Sales by Type (2021-2032)
  4. 11.1.3 Asia Red Blood Cell Products Price by Type (2021-2032)
  5. 11.2 Asia Red Blood Cell Products Market Size by Application
  6. 11.2.1 Asia Red Blood Cell Products Revenue by Application (2021-2032)
  7. 11.2.2 Asia Red Blood Cell Products Sales by Application (2021-2032)
  8. 11.2.3 Asia Red Blood Cell Products Price by Application (2021-2032)
  9. 11.3 Asia Red Blood Cell Products Market Size by Country
  10. 11.3.1 Asia Red Blood Cell Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Red Blood Cell Products Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Red Blood Cell Products Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Red Blood Cell Products Market Size by Type
  2. 12.1.1 SAMEA Red Blood Cell Products Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Red Blood Cell Products Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Red Blood Cell Products Price by Type (2021-2032)
  5. 12.2 SAMEA Red Blood Cell Products Market Size by Application
  6. 12.2.1 SAMEA Red Blood Cell Products Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Red Blood Cell Products Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Red Blood Cell Products Price by Application (2021-2032)
  9. 12.3 SAMEA Red Blood Cell Products Market Size by Country
  10. 12.3.1 SAMEA Red Blood Cell Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Red Blood Cell Products Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Red Blood Cell Products Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Red Blood Cell Products Value Chain Analysis
  2. 13.1.1 Red Blood Cell Products Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Red Blood Cell Products Production Mode & Process
  6. 13.2 Red Blood Cell Products Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Red Blood Cell Products Distributors
  9. 13.2.3 Red Blood Cell Products Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst